About 9 results found for searched term "93-62-9" (0.053 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5731 | LCZ696 | Angiotensin Receptor |
| Sacubitril/Valsartan；Entresto | ||
| LCZ696, consisting of Valsartan and Sacubitril in a 1:1 molar ratio, is a first-in-class dual-action angiotensin receptor-neprilysin inhibitor (ARNi,angiotensin receptor-neprilysin inhibitor) for the study of hypertension and heart failure. | ||
| M7355 | TAS 301 | Others |
| TAS 301 is a inhibitor of smooth muscle cell migration and proliferation. | ||
| M21987 | Cobimetinib racemate | MEK |
| Cobimetinib racemate is the racemate of Cobimetinib, a potent, selective, orally available MEK1 inhibitor with an IC50 for MEK1 inhibition of 4.2 nM.In addition, Cobimetinib is an Akt inhibitor. | ||
| M29000 | K134 | PDE |
| OPC33509 | ||
| K134 is a phosphodiesterase 3 (PDE3) inhibitor. The IC50s of K134 toward PDE3A, PDE3B, PDE5, PDE2 and PDE4 are 0.1, 0.28, 12.1, >300 and >300 µM, respectively. | ||
| M38925 | Ivaltinostat | HDAC |
| Ivaltinostat (CG-200745) is an orally active, potent pan-HDAC inhibitor which inhibits deacetylation of histone H3 and tubulin. Ivaltinostat induces the accumulation of p53, promotes p53-dependent transactivation, and enhances the expression of MDM2 and p21 (Waf1/Cip1) proteins. | ||
| M41181 | GS-9822 | Anti-infection |
| GS-9822 is a potent antivira agent with nanomolar activity against wild-type HIV-1 viruses. | ||
| M41794 | SB-649701 | CCR |
| SB-649701 is a potent human CCR8 antagonist, with a pIC50 of 7.7. | ||
| M51949 | N-(2-Hydroxyethyl)iminodiacetic Acid | Amino Acid Derivatives |
| N-(2-Hydroxyethyl)iminodiacetic Acid is a Glycine derivative. | ||
| M54528 | Dargistotug | TIGIT |
| M-6223 | ||
| Dargistotug is a fully human IgG1 monoclonal antibody targeting T-cell immunoglobulin and the ITIM structural domain (TIGIT) that induces an immune response targeting cancer cells by blocking the TIGIT pathway. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
